Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood

By LabMedica International staff writers
Posted on 19 Oct 2026

Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. More...

Specific IgE antibodies may be detectable even when a child has no symptoms after eating the implicated food, complicating interpretation. Yet detailed North American data on how these antibody responses change during early childhood have been limited.

To better characterize these changes, a new study tracked IgE sensitization patterns between infancy and age 5. The analysis focused on responses to allergen extracts and individual allergen components, assessing sensitization rather than confirmed clinical allergy. This longitudinal approach allowed the team to examine whether sensitization persisted, disappeared, or emerged later in childhood.

The researchers analyzed samples from 500 mother-child pairs enrolled in the Canadian CHILD Study, with blood collected from mothers during pregnancy and from children at ages 1 and 5. Testing covered approximately 300 allergen extracts and individual components, allowing the team to characterize how sensitization changed during early childhood.

Specific IgE sensitization was detected in 25.3% of children at age 1, rising to 40.4% by age 5. Egg and peanut were among the main food sensitizers in infancy, while peanut and tree nuts predominated at age 5. Over the same period, sensitization to environmental allergens, including cats, dogs, house dust mites, and grass pollen, also became more common.

Within these broader changes, peanut and tree nut sensitization followed distinct trajectories. Approximately half of children sensitized to major peanut components at 12 months remained sensitized at age 5. In contrast, sensitization to important components of cashew, hazelnut, walnut, and pistachio often emerged later in childhood.

Other responses diminished over time, with approximately one in four children losing sensitization to important 2S albumins during the four-year period. These proteins include major allergen components of peanut, tree nuts, and sesame and serve as useful markers for food allergies associated with systemic reactions.

Published in Allergy on September 16, 2026, the study involved the Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten, a teaching and research site of Karl Landsteiner University of Health Sciences (Krems an der Donau, Austria), alongside Canadian universities and pediatric research centers, including the Hospital for Sick Children (SickKids; Toronto, Canada). 

The authors emphasized that oral food challenges were not performed to confirm clinical food allergy. The observed loss of sensitization therefore does not mean that one in four children outgrew an established food allergy.

“Especially in young children, a positive allergy test is not necessarily the end of the story. We need to know whether a sensitization persists, disappears or develops later. Looking at individual allergen components gives us valuable information for discussing risks and treatment options with families,” said Thomas Eiwegger, head of the Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten.

Related Links
Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten
Hospital for Sick Children


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dr. Maria “Ken” Figueroa is investigating how epigenetics can inform treatment paths for cancer patients. (Image Credit: Sylvester Comprehensive Cancer Center)

DNA Methylation May Predict Treatment Response in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are disorders in which the bone marrow does not produce healthy blood cells normally. Treatment selection can be challenging because clinicians cannot reliably predict which... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.